Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
3(50%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_1
2
33%
Ph phase_4
1
17%
Ph phase_3
2
33%
Ph phase_2
1
17%

Phase Distribution

2

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(3)
Completed(3)

Detailed Status

Recruiting3
Completed3

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 21 (16.7%)
Phase 32 (33.3%)
Phase 41 (16.7%)

Trials by Status

recruiting350%
completed350%

Recent Activity

3 active trials
Showing 5 of 6
recruitingphase_3

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

NCT07160244
recruitingphase_1

A Study of V118E in Healthy Participants (V118E-003)

NCT07168915
completedphase_3

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

NCT03621670
recruitingphase_4

Vaccine Responses in Patients With B Cell Malignancies

NCT05170399
completedphase_1

A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)

NCT06611033
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07160244Phase 3

BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies

Recruiting
NCT07168915Phase 1

A Study of V118E in Healthy Participants (V118E-003)

Recruiting
NCT03621670Phase 3

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Completed
NCT05170399Phase 4

Vaccine Responses in Patients With B Cell Malignancies

Recruiting
NCT06611033Phase 1

A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)

Completed
NCT05412030Phase 2

A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants

Completed

All 6 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
6